Related Experiment Videos
Construction of chimaeric processed immunoglobulin genes containing mouse variable and human constant region
Nature
|April 4, 1985
Summary
Chimeric antibodies combine mouse and human genes to reduce immune reactions in cancer diagnostics and therapies. This method precisely splices genes, enabling expression in various cells for improved treatments.
Area of Science:
- Immunology
- Molecular Biology
- Biotechnology
Background:
- Monoclonal antibodies offer specificity for diagnosing and treating human neoplasia.
- Mouse antibodies face neutralization due to immune reactions from repeated administration of heterologous antibodies.
- Chimeric immunoglobulins, combining mouse variable and human constant regions, can mitigate these immune responses.
Purpose of the Study:
- To construct a chimaeric immunoglobulin gene by combining mouse and human genetic elements.
- To demonstrate precise splicing of chimaeric intervening sequences within a recombinant retrovirus DNA construct.
- To establish a method for expressing chimaeric mouse-human immunoglobulin genes in various cell systems.
Main Methods:
- Construction of recombinant retrovirus DNA carrying specific heavy-chain (H) variable-diversity joining (VH-D-JH) and C gamma 1 genes.
- Utilizing genes from different species to create the chimaeric construct.
- Analysis of gene splicing to confirm precise removal of intervening sequences.
Main Results:
- Successful construction of a recombinant retrovirus DNA encoding chimaeric immunoglobulin genes.
- Precise splicing of chimaeric intervening sequences was confirmed.
- Demonstrated a method for expressing chimaeric mouse-human immunoglobulin genes in Escherichia coli, yeast, and animal cells.
- Observed unexpected use of a hidden splice donor site, leading to V region formation without a leader sequence.
Conclusions:
- The developed procedure effectively constructs chimaeric mouse-human immunoglobulin genes.
- This method facilitates the expression of these genes in diverse cellular systems for potential therapeutic applications.
- The unexpected splicing event highlights a novel aspect of V region gene formation.